NCT06314594 Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform
| NCT ID | NCT06314594 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hangzhou Medical College |
| Condition | Adolescent Idiopathic Scoliosis (AIS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2025-08-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Spinal cord injury (SCI), leads to functional deficits and complications like neurogenic bladder and deep vein thrombosis, imposing a global annual financial burden. This trial aims to compares Jiaji electroacupuncture (JEA) and scalp electroacupuncture (SEA) in SCI rehabilitation. This randomized controlled trial (RCT) compared JEA and SEA in SCI rehabilitation.
Eligibility Criteria
Inclusion Criteria: 1. The diagnosis of moderate and mild AIS, with a Cobb angle measuring less than 45°; 2. The age range of 12 to 16 years old; 3. Participants are required to have no history of mental illness, possess normal communication skills, and be proficient in reading and writing; 4. Signed informed consent by the patient or their family. Exclusion Criteria: Patients who fulfill any of the following conditions will be excluded a clear history of inducement, such as diseases caused by trauma, surgery, cognitive impairment, severe dysfunction of heart, liver, kidney and other organs, and malignant tumors, immune diseases and other malignant diseases.
Contact & Investigator
Xinyun Dr Li, doctor
PRINCIPAL INVESTIGATOR
hangzhou medical colleage
Frequently Asked Questions
Who can join the NCT06314594 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 18 Years, studying Adolescent Idiopathic Scoliosis (AIS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06314594 currently recruiting?
Yes, NCT06314594 is actively recruiting participants. Contact the research team at lxyjasmine2010@163.com for enrollment information.
Where is the NCT06314594 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06314594 clinical trial?
NCT06314594 is sponsored by Hangzhou Medical College. The principal investigator is Xinyun Dr Li, doctor at hangzhou medical colleage. The trial plans to enroll 76 participants.